Concepedia

Michal Shreberk‐Shaked

MS

Statistics

Publications

5

Citations

361

H-Index

5

Active since

2018

Affiliations

Weizmann Institute of Science(Current)

Tata Memorial Hospital

Advanced Centre for Treatment, Research and Education in Cancer

University of Maryland, College Park

Michal Shreberk‐Shaked is an author at Weizmann Institute of Science specializing in transcriptional regulation, tumor biology, and cancer genetics.

ORCID

Top concepts

Publications per year

2018–2022

5

Publications

5

<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment

Martino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj et al. · Proceedings of the National Academy of Sciences · 2021 · 111 citations · Full text

Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients

Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked et al. · Nature Communications · 2022 · 97 citations · Full text

, , +18

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

Amir Kedan, Nandini Verma, Ashish Saroha et al. · Cell Death and Disease · 2018 · 66 citations · Full text

A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer

Michal Shreberk‐Shaked, Bareket Dassa, Sanju Sinha et al. · Cancer Research · 2020 · 62 citations · Full text

Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins

Saptaparna Mukherjee, Martino Maddalena, YiQing Lü et al. · Proceedings of the National Academy of Sciences · 2022 · 25 citations · Full text

, , +16

Rows per page

1–5 of 5